Risto Arvo Sakari Lammintausta
Oprichter bij Forendo Pharma Oy
Profiel
Risto Arvo Sakari Lammintausta was the founder of Juvantia Pharma Oy (founded in 1997), Hormos Medical Oy (founded in 1997), and Forendo Pharma Oy (founded in 2013) where he previously holds the title of Chief Executive Officer & Director.
He previously worked as a Vice President-New Drug Development at Orion Corp I from 1992 to 1997.
He also held director positions at Innomedica Oy and Faron Pharmaceuticals Oy.
Dr. Lammintausta earned a doctorate degree from the University of Turku.
Actieve functies van Risto Arvo Sakari Lammintausta
Bedrijven | Functie | Begin |
---|---|---|
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Oprichter | 16-01-2013 |
Eerdere bekende functies van Risto Arvo Sakari Lammintausta
Bedrijven | Functie | Einde |
---|---|---|
Orion Corp I
Orion Corp I SemiconductorsElectronic Technology Part of Applied Materials, Inc., Orion Corp I is a leading company in the field of autoid and sap. The company is based in Santa Clara, CA and offers solutions that make logistics even stronger, supporting the entire supply chain from project consulting and support to software development for diverse needs. The company's opal security platform, backed by Greylock, enables organizations to implement least privilege at scale. Opal decentralizes access management away from overburdened teams through a combination of insights and workflows. Opal can be deployed on-premise and cloud in minutes without using agents or proxies. | Corporate Officer/Principal | 01-01-1997 |
FARON PHARMACEUTICALS OY | Directeur/Bestuurslid | - |
Innomedica Oy
Innomedica Oy Miscellaneous Commercial ServicesCommercial Services Innomedica is an international business consulting company serving the biotechnology and pharmaceutical industries. It provides a range of professional business development and project management services to its clients in both the public and private sectors. Innomedica's service portfolio includes Business Development, Licensing & Partnering, Japan Markets and Project Management. It is active on a global basis, though it specializes in the North European and Japanese markets. Its people are its main asset. Its success is based on leveraging the experience of professionals from different disciplines to deliver value to its clients. Its team portrays backgrounds from experienced business people to skilled lawyers and biomedical scientists. Innomedica was founded in 1997, and is a privately held company. Its client base covers both private and public sectors, both large and small. | Directeur/Bestuurslid | - |
Juvantia Pharma Oy
Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Oprichter | - |
Hormos Medical Oy
Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Algemeen Directeur | - |
Opleiding van Risto Arvo Sakari Lammintausta
University of Turku | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
FARON PHARMACEUTICALS OY | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Orion Corp I
Orion Corp I SemiconductorsElectronic Technology Part of Applied Materials, Inc., Orion Corp I is a leading company in the field of autoid and sap. The company is based in Santa Clara, CA and offers solutions that make logistics even stronger, supporting the entire supply chain from project consulting and support to software development for diverse needs. The company's opal security platform, backed by Greylock, enables organizations to implement least privilege at scale. Opal decentralizes access management away from overburdened teams through a combination of insights and workflows. Opal can be deployed on-premise and cloud in minutes without using agents or proxies. | Electronic Technology |
Juvantia Pharma Oy
Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Commercial Services |
Hormos Medical Oy
Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Health Technology |
Innomedica Oy
Innomedica Oy Miscellaneous Commercial ServicesCommercial Services Innomedica is an international business consulting company serving the biotechnology and pharmaceutical industries. It provides a range of professional business development and project management services to its clients in both the public and private sectors. Innomedica's service portfolio includes Business Development, Licensing & Partnering, Japan Markets and Project Management. It is active on a global basis, though it specializes in the North European and Japanese markets. Its people are its main asset. Its success is based on leveraging the experience of professionals from different disciplines to deliver value to its clients. Its team portrays backgrounds from experienced business people to skilled lawyers and biomedical scientists. Innomedica was founded in 1997, and is a privately held company. Its client base covers both private and public sectors, both large and small. | Commercial Services |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Health Technology |